Working… Menu

A Phase I Study to Assess Safety, Tolerability and Pharmacokinetics of OP0595

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT02134834
Recruitment Status : Completed
First Posted : May 9, 2014
Last Update Posted : December 12, 2014
Information provided by (Responsible Party):
Meiji Seika Pharma Co., Ltd.